Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,099 | 224,462 | 37,318 | 51,802 | 90,672 |
| Marketable Securities | 518,141 | 502,933 | 386,639 | 386,183 | 427,288 |
| Receivables | 8,804 | 2,060 | N/A | N/A | N/A |
| Inventories | 413 | N/A | N/A | N/A | N/A |
| TOTAL | $708,663 | $744,829 | $432,481 | $446,426 | $522,289 |
| Non-Current Assets | |||||
| PPE Net | 7,855 | 1,682 | 1,859 | 2,540 | 2,673 |
| Other Non-Current Assets | 21,845 | 13,648 | 14,595 | 7,340 | 9,089 |
| TOTAL | $29,700 | $15,330 | $16,454 | $9,880 | $11,762 |
| Total Assets | $738,363 | $760,159 | $448,935 | $456,306 | $534,051 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,607 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,017 | 1,469 | 33,757 | 21,739 | 20,192 |
| Accrued Expenses | 61,697 | 48,484 | N/A | N/A | N/A |
| Other current liabilities | 48,983 | 24,271 | N/A | N/A | N/A |
| TOTAL | $116,974 | $78,712 | $35,263 | $24,057 | $22,455 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,711 | 6,916 | 9,332 | 9,158 | 0 |
| Other Non-Current Liabilities | 437,543 | 260,891 | 7,067 | 2,813 | 4,987 |
| TOTAL | $447,254 | $267,807 | $16,399 | $11,971 | $4,987 |
| Total Liabilities | $564,228 | $346,519 | $51,662 | $36,028 | $27,442 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,330 | 80,755 | 76,137 | 68,439 | 66,614 |
| Common Shares | 9 | 8 | 7 | 7 | 7 |
| Retained earnings | -1,174,088 | -895,422 | -721,439 | -568,808 | -432,968 |
| Other shareholders' equity | 1,024 | 764 | -1,271 | -8,032 | -1,789 |
| TOTAL | $174,135 | $413,640 | $397,273 | $420,278 | $506,609 |
| Total Liabilities And Equity | $738,363 | $760,159 | $448,935 | $456,306 | $534,051 |